ArticleDiabetologia2018

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.

Suzy V Hope et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.